Search research articles
Contact Us
Filters
Showing results (21-30 of 442) with videos related to
Page
of 45
Sort By:
Journal for Immunotherapy of Cancer
|
July 11, 2024
A crisis in clinical research
David S Hong, Patricia LoRusso, Mario Sznol
Frontiers in Oncology
|
May 17, 2024
KRAS G12C inhibitor combination therapies: current evidence and challenge
Hirotaka Miyashita, Shumei Kato, David S Hong
Clinical Advances in Hematology & Oncology : H&O
|
July 2, 2024
Efficacy and safety of NTRK inhibitors in patients with NTRK fusion-positive lung and thyroid cancers
David S Hong, Alexander Drilon, Lori J Wirth
Journal of Developmental and Behavioral Pediatrics : JDBP
|
July 12, 2011
Psychosocial functioning and social cognitive processing in girls with Turner syndrome
David S Hong, Bria Dunkin, Allan L Reiss
Translation (Austin, Tex.)
|
January 19, 2016
Targeting translation initiation in breast cancer
Argun Akcakanat, David S Hong, Funda Meric-Bernstam
Clinical Advances in Hematology & Oncology : H&O
|
July 2, 2024
Q&A: Barriers to testing for NTRK fusions in metastatic lung and thyroid cancer
David S Hong, Alexander Drilon, Lori J Wirth
Cancer Treatment Reviews
|
September 10, 2016
RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
Pedro Barata, Anil K Sood, David S Hong
Cancer
|
September 13, 2007
Interleukin-6 and its receptor in cancer: implications for translational therapeutics
David S Hong, Laura S Angelo, Razelle Kurzrock
Proceedings of the National Academy of Sciences of the United States of America
|
February 27, 2016
Clinical activity of ceritinib in ROS1-rearranged non-small cell lung cancer: Bench to bedside report
Vivek Subbiah, David S Hong, Funda Meric-Bernstam
JCO Precision Oncology
|
September 28, 2023
Important Considerations for Real-World Analysis of Neurotrophic Tyrosine Receptor Kinase Fusion Cancer and Tropomyosin Receptor Kinase Inhibitors
Marcia S Brose, David S Hong, Alexander Drilon
Page
of 45
Search research articles
Search
Showing results (21-30 of 442) with videos related to
Sort By:
Page
of 45
Journal for Immunotherapy of Cancer
|
July 11, 2024
A crisis in clinical research
David S Hong, Patricia LoRusso, Mario Sznol
Frontiers in Oncology
|
May 17, 2024
KRAS G12C inhibitor combination therapies: current evidence and challenge
Hirotaka Miyashita, Shumei Kato, David S Hong
Clinical Advances in Hematology & Oncology : H&O
|
July 2, 2024
Efficacy and safety of NTRK inhibitors in patients with NTRK fusion-positive lung and thyroid cancers
David S Hong, Alexander Drilon, Lori J Wirth
Journal of Developmental and Behavioral Pediatrics : JDBP
|
July 12, 2011
Psychosocial functioning and social cognitive processing in girls with Turner syndrome
David S Hong, Bria Dunkin, Allan L Reiss
Translation (Austin, Tex.)
|
January 19, 2016
Targeting translation initiation in breast cancer
Argun Akcakanat, David S Hong, Funda Meric-Bernstam
Clinical Advances in Hematology & Oncology : H&O
|
July 2, 2024
Q&A: Barriers to testing for NTRK fusions in metastatic lung and thyroid cancer
David S Hong, Alexander Drilon, Lori J Wirth
Cancer Treatment Reviews
|
September 10, 2016
RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
Pedro Barata, Anil K Sood, David S Hong
Cancer
|
September 13, 2007
Interleukin-6 and its receptor in cancer: implications for translational therapeutics
David S Hong, Laura S Angelo, Razelle Kurzrock
Proceedings of the National Academy of Sciences of the United States of America
|
February 27, 2016
Clinical activity of ceritinib in ROS1-rearranged non-small cell lung cancer: Bench to bedside report
Vivek Subbiah, David S Hong, Funda Meric-Bernstam
JCO Precision Oncology
|
September 28, 2023
Important Considerations for Real-World Analysis of Neurotrophic Tyrosine Receptor Kinase Fusion Cancer and Tropomyosin Receptor Kinase Inhibitors
Marcia S Brose, David S Hong, Alexander Drilon
Page
of 45